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Background:  The efficacy of transplantation of marrow-derived mesenchymal stem cell (MSC) was modest. Previously, we reported that the 
pretreatment of human MSC with pioglitazone (Pio) dramatically improved the cardiomyogenic transdifferentiation and cardiac function in nude rat 
myocardial infarction (MI) model. In the present study, we confirmed the effect of autologus MSCs and Pio on cardiac function in beagles.
Methods & Results:  The MSC was collected from iliac bone marrow and MI was made by ligation of LAD in anesthetized open-chest beagles (BW 
10-11kg). The beagles were divided into three groups and blinded. Two weeks after the operation, Pio-pretreated autologus MSCs (1μM for 2 weeks, 
5x10^7 cells; p-MSC group), default MSCs (5x10^7 cells; MSC group), or control medium (control MI group) were injected in MI area. Two weeks 
after the transplantation, changes left ventricular ejection fraction (2 weeks after the transplantation - immediately before the transplantation; 
ΔLVEF) measured by echocardiogram, left ventricular systolic pressure (LVSP) and %MI volume (%MIVOL) were compared. Compared to MSC group, 
LVEF, LVSP, and %MIVOL were significantly improved in p-MSC group.
Conclusions:  Transplantation of Pio-pretreated MSCs decreased MI area and restored the LV function significantly in beagle MI model. 
Pioglitazone-activated MSC can restore the efficacy of present cardiac stem cell therapy. 
